Share:
Editorial

Melanocytic Skin Tumors: Does the Molecular Progression Model Fit With the Routine Clinicopathological Practice?

Author Affiliation(s)

Conclusions

The correlation between molecular and histopathological features of melanocytic tumors is still largely incomplete. From a practical point of view, however, only a very limited number of cases seen in clinical practice run the entire spectrum of molecular and biological progression of melanomagenesis; thus, the molecular progression model has a very limited clinical impact. Rather than intermediate stages in an unlikely path toward melanoma, melanocytomas are probably best regarded as morphobiologically peculiar melanocytic tumors, namely, strongly lymphotropic (low-grade) melanocytic malignancies; their clinical management should be thus discussed case by case in a multidisciplinary setting by integrating the histopathological findings with the clinical data.

References

  1. Genomic landscape of melanoma Bastian BC, de la Fouchardiere A, Elder DE, et al. Elder DE, Massi D, Scolyer RA, Willemze R. WHO Classification of Skin Tumours.2018;:72-75.
  2. An update on molecular alterations in melanocytic tumors with emphasis on spitzoid lesions Dimonitsas E, Liakea A, Sakellariou S, et al. Ann Transl Med.2018;6(12):249-265.
  3. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression Wiesner T, Murali R, Fried I, et al. Am J Surg Pathol.2012;36(6):818-830.
  4. Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi Yeh I, Lang UE, Durieux E, et al. Nat Commun.2017;8(1):644.
  5. Genomic analysis of pigmented epithelioid melanocytomas reveals recurrent alterations in PRKAR1A, and PRKCA genes Cohen JN, Joseph NM, North JP, et al. Am J Surg Pathol.2017;41(10):1333-1346.
  6. Genomics of cutaneous melanoma: focus on next-generation sequencing approaches and bioinformatics Papadodima O, Kontogianni G, Piroti G, Maglogianni I, Chatziioannou A. J Transl Genet Genom.2019;3:7.
  7. Nevus/melanocytoma/melanoma: an emerging paradigm for classification of melanocytic neoplasms? Zembovicz A, Scolyer RA. Arch Pathol Lab Med.2011;135(3):300-306.
  8. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate Tsao H, Bevona C, Goggins W, Quinn T. Arch Dermatol.2003;139(3):282-288.
  9. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors De la Fouchardière A, Caillot C, Jacquemus J, et al. Virchows Arch.2019;474(5):539-550.
  10. Molecular diagnostics in melanocytic tumors: the pathologist’s perspective Ferrara G, Improta G. Adv Mol Diag.2016;1(1).
  11. Fluorescence in-situ hybridization for melanoma diagnosis: a review and a reappraisal Ferrara G, De Vanna AC. Am J Dermatopathol.2016;38(4):253-269.
  12. Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008 Cerroni L, Barnhill R, Elder D, et al. Am J Surg Pathol.2010;34(3):314-326.
  13. Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review Lallas A, Krygidis A, Ferrara G, et al. Lancet Oncol.2014;15(4):e178-e183..

Send mail to Author


Send Cancel